Mirzyme Therapeutics

About:

MirZyme is an innovative company focused on the development of tailored therapeutics to prevent preeclampsia and fetal growth restriction.

Website: http://www.mirzyme.com

Twitter/X: mirzyme

Description:

MirZyme Therapeutics is an innovative biopharmaceutical company focused on the development and commercialisation of tailored therapeutics to prevent preeclampsia and fetal growth restriction in pregnancy. MirZyme provides a stratified approach to identify patients who will develop preeclampsia and has developed first in class drugs to prevent preeclampsia and fetal growth restrictions. We have two therapeutic approaches, small molecules in capsules form and injectable synthetic miRNAs. MirZyme. One Test. One Pill. Save Two Lives.

Total Funding Amount:

$2.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Birmingham, Birmingham, United Kingdom

Founded Date:

2016-04-19

Contact Email:

info(AT)mirzyme.com

Founders:

Asif Ahmed

Number of Employees:

11-50

Last Funding Date:

2018-08-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai